Burning Rock Biotech (BNR) Cash from Investing Activities (2019 - 2026)
Burning Rock Biotech (BNR) posted quarterly Cash from Investing Activities of -$53000.0 for Q1 2026, up 74.88% year-over-year from -$30306.2 in Q1 2025, and down 15.22% on a QoQ basis from -$46000.0 in Q4 2025.
Burning Rock Biotech (BNR) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Burning Rock Biotech (BNR) has reported Cash from Investing Activities for 8 consecutive years, with -$53000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 74.88% year-over-year to -$53000.0; the TTM figure through Mar 2026 stood at -$670000.0 (up 22.63% YoY), while the FY2025 annual figure was -$628000.0, down 3.97% from the prior year.
- Cash from Investing Activities came in at -$53000.0 for Q1 2026 at Burning Rock Biotech, down from -$46000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $4.6 million in Q2 2022, with the low at -$2.8 million in Q3 2022.
- Average Cash from Investing Activities over 5 years is -$247117.6, with a median of -$272000.0 recorded in 2023.
- Across the five-year window, Cash from Investing Activities surged 143.87% in 2022 and sank 496.77% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$730000.0 in 2022, then jumped by 93.7% to -$46000.0 in 2023, then sank by 141.3% to -$111000.0 in 2024, then jumped by 58.56% to -$46000.0 in 2025, then retreated by 15.22% to -$53000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$53000.0, -$46000.0, and -$386000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Burning Rock Biotech | 748.66 Mn | 683.48 Mn | 11.31 Mn | -53,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53,000.00 |
| Mar 31, 2026 | -53,000.00 |
| Dec 31, 2025 | -46,000.00 |
| Dec 31, 2025 | -46,000.00 |
| Sep 30, 2025 | -386,000.00 |
| Sep 30, 2025 | -386,000.00 |
| Jun 30, 2025 | -185,000.00 |
| Jun 30, 2025 | -185,000.00 |
| Mar 31, 2025 | -211,000.00 |
| Mar 31, 2025 | -211,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Jun 30, 2024 | -31,000.00 |
| Jun 30, 2024 | -31,000.00 |
| Mar 31, 2024 | -330,000.00 |
| Mar 31, 2024 | -330,000.00 |
| Dec 31, 2023 | -46,000.00 |
| Dec 31, 2023 | -46,000.00 |